These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3995712

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
    Houde C, Bohn DJ, Freedom RM, Rabinovitch M.
    Br Heart J; 1993 Nov; 70(5):461-8. PubMed ID: 8260279
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vasodilator therapy for primary pulmonary hypertension in children.
    Barst RJ, Maislin G, Fishman AP.
    Circulation; 1999 Mar 09; 99(9):1197-208. PubMed ID: 10069788
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [10 years' experience in the use of vasodilator agents in the treatment of primary pulmonary arterial hypertension (P-PAH) (1977-1987)].
    Beltrán Gámez ME, Sandoval Zarate J, Seoane M, Lupi-Herrera E.
    Arch Inst Cardiol Mex; 1988 Mar 09; 58(4):281-91. PubMed ID: 3190363
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Therapy of primary pulmonary arterial hypertension: current status].
    Solèr M.
    Schweiz Med Wochenschr; 1994 Oct 01; 124(39):1701-7. PubMed ID: 7939536
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T, Ozawa Y, Nakayama T, Matsuura H, Hashiguchi R, Matsuo N, Muto H, Yamazaki J, Morishita T, Saito T.
    J Cardiol; 1996 Apr 01; 27(4):197-205. PubMed ID: 8642506
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
    Lupi-Herrera E, Seoane M, Verdejo J, Gomez A, Sandoval J, Barrios R, Martinez W.
    Chest; 1985 May 01; 87(5):564-73. PubMed ID: 3987368
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
    Hermiller JB, Bambach D, Thompson MJ, Huss P, Fontana ME, Magorien RD, Unverferth DV, Leier CV.
    Ann Intern Med; 1982 Oct 01; 97(4):480-9. PubMed ID: 7125407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.